Market Closed -
Australian S.E.
07:10:43 01/05/2024 BST
|
5-day change
|
1st Jan Change
|
6.8
AUD
|
-2.44%
|
|
-4.49%
|
+10.57%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
807.3
|
646.4
|
564.7
|
441.2
|
366.6
|
551.8
|
-
|
-
|
Enterprise Value (EV)
1 |
1,088
|
906.7
|
813.6
|
758.2
|
321.5
|
479.7
|
490.9
|
473.8
|
P/E ratio
|
-2.68
x
|
-6.34
x
|
-2.41
x
|
-1.56
x
|
2.97
x
|
-6.81
x
|
-203
x
|
31.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.54
x
|
1.41
x
|
1.41
x
|
1.04
x
|
2
x
|
1.44
x
|
1.28
x
|
1.12
x
|
EV / Revenue
|
2.07
x
|
1.98
x
|
2.03
x
|
1.78
x
|
1.75
x
|
1.25
x
|
1.14
x
|
0.96
x
|
EV / EBITDA
|
8.31
x
|
9.51
x
|
12.8
x
|
16.6
x
|
-3.37
x
|
20.3
x
|
7.55
x
|
4.54
x
|
EV / FCF
|
11,486,336
x
|
20,651,950
x
|
19,477,342
x
|
-44,043,229
x
|
-6,298,425
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
0%
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
0.8
x
|
0.62
x
|
0.73
x
|
0.78
x
|
0.58
x
|
1.08
x
|
1.16
x
|
1.18
x
|
Nbr of stocks (in thousands)
|
79,147
|
83,953
|
88,242
|
88,242
|
83,324
|
81,148
|
-
|
-
|
Reference price
2 |
10.20
|
7.700
|
6.400
|
5.000
|
4.400
|
6.970
|
6.970
|
6.970
|
Announcement Date
|
22/08/19
|
20/08/20
|
26/08/21
|
25/08/22
|
30/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
525.2
|
457
|
400.8
|
424.8
|
183.6
|
384.3
|
429.5
|
492.8
|
EBITDA
1 |
130.9
|
95.3
|
63.5
|
45.7
|
-95.3
|
23.69
|
65.04
|
104.5
|
EBIT
1 |
37.2
|
11.7
|
-3.7
|
-34.5
|
-160.7
|
-46.66
|
-19.82
|
28.07
|
Operating Margin
|
7.08%
|
2.56%
|
-0.92%
|
-8.12%
|
-87.53%
|
-12.14%
|
-4.62%
|
5.7%
|
Earnings before Tax (EBT)
|
-353.7
|
-135.4
|
-263.9
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-280.9
|
-92.8
|
-208.4
|
-263.3
|
117.2
|
-83.7
|
-2.791
|
17.76
|
Net margin
|
-53.48%
|
-20.31%
|
-52%
|
-61.99%
|
63.87%
|
-21.78%
|
-0.65%
|
3.6%
|
EPS
2 |
-3.808
|
-1.214
|
-2.652
|
-3.200
|
1.480
|
-1.023
|
-0.0344
|
0.2186
|
Free Cash Flow
|
94.69
|
43.9
|
41.77
|
-17.22
|
-51.05
|
-
|
-
|
-
|
FCF margin
|
18.03%
|
9.61%
|
10.42%
|
-4.05%
|
-27.81%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
72.34%
|
46.07%
|
65.78%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/08/19
|
20/08/20
|
26/08/21
|
25/08/22
|
30/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
227.2
|
229.8
|
208.8
|
192
|
195.6
|
228.4
|
-
|
82.42
|
187.9
|
201
|
202.7
|
EBITDA
|
47.4
|
47.9
|
39.9
|
23.6
|
23.7
|
22
|
-
|
-42.2
|
-
|
-
|
-
|
EBIT
|
-12.3
|
24
|
2.3
|
-6
|
-17.6
|
-16.9
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-5.41%
|
10.44%
|
1.1%
|
-3.13%
|
-9%
|
-7.4%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-24.96
|
-110.4
|
-229.3
|
-34.63
|
-63.7
|
-154.1
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-17.5
|
-75.3
|
-181.3
|
-27.11
|
-50.4
|
-213
|
290
|
-
|
-70.55
|
-
|
-
|
Net margin
|
-7.7%
|
-32.77%
|
-86.81%
|
-14.12%
|
-25.77%
|
-93.26%
|
-
|
-
|
-37.54%
|
-
|
-
|
EPS
|
-0.2400
|
-
|
-2.320
|
-0.3320
|
-0.6200
|
-2.580
|
0.1760
|
-
|
-0.8780
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
20/08/20
|
23/02/21
|
26/08/21
|
24/02/22
|
25/08/22
|
27/02/23
|
30/08/23
|
25/02/24
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
280
|
260
|
249
|
317
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
45.1
|
72.1
|
60.9
|
78
|
Leverage (Debt/EBITDA)
|
2.142
x
|
2.731
x
|
3.919
x
|
6.936
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
94.7
|
43.9
|
41.8
|
-17.2
|
-51
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
1.26%
|
-1.25%
|
-3.14%
|
-18.8%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
0.81%
|
-0.74%
|
-1.73%
|
-9.13%
|
-
|
-
|
-
|
-
|
Assets
1 |
-34,530
|
12,520
|
12,071
|
2,883
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
12.70
|
12.40
|
8.710
|
6.400
|
7.600
|
6.450
|
6.000
|
5.900
|
Cash Flow per Share
2 |
1.450
|
1.260
|
0.7100
|
-0.0900
|
-0.5200
|
-0.6900
|
0.4400
|
0.8000
|
Capex
1 |
11.9
|
8.99
|
17.1
|
10
|
8.34
|
8.67
|
12.6
|
11.3
|
Capex / Sales
|
2.27%
|
1.97%
|
4.26%
|
2.36%
|
4.54%
|
2.26%
|
2.93%
|
2.3%
|
Announcement Date
|
22/08/19
|
20/08/20
|
26/08/21
|
25/08/22
|
30/08/23
|
-
|
-
|
-
|
Last Close Price
6.97
AUD Average target price
7.035
AUD Spread / Average Target +0.93% Consensus |
1st Jan change
|
Capi.
|
---|
| +10.57% | 367M | | +19.27% | 43.18B | | +24.05% | 23.23B | | +15.11% | 14.6B | | +38.36% | 11.5B | | -7.63% | 6.79B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +10.21% | 5.31B | | -2.27% | 4.81B |
Generic Pharmaceuticals
|